Despite increases in overall mental health drug utilization, costs per person declined by nearly 5% between 2020 and 2021, according to a new report from EmpiRx, a value-based PBM.
Despite increases in overall mental health drug utilization, costs per person declined by nearly 5% between 2020 and 2021, according to a new report from EmpiRx, a value-based PBM.